Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

About Lite Strategy

Founded

2018

Community

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Fundrasing details

Funding RoundAmountValuation
Date
Investors
Post-IPO
$100.00M
--
2025-07-21
--